- Home
- NGS vs ALDX Comparison
NGS vs ALDX Comparison
Compare NGS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGS | ALDX |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.9M | 293.0M |
| IPO Year | 2002 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NGS | ALDX |
|---|---|---|
| Price | $33.47 | $4.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $35.67 | $9.50 |
| AVG Volume (30 Days) | 99.9K | ★ 971.9K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | ★ 14.85 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $166,824,000.00 | N/A |
| Revenue This Year | $9.50 | N/A |
| Revenue Next Year | $13.88 | $36.25 |
| P/E Ratio | $22.72 | ★ N/A |
| Revenue Growth | ★ 9.53 | N/A |
| 52 Week Low | $16.73 | $1.14 |
| 52 Week High | $33.82 | $7.20 |
Technical Indicators
Market Signals| Indicator | NGS | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 69.78 | 39.04 |
| Support Level | $31.63 | $4.67 |
| Resistance Level | $33.82 | $5.04 |
| Average True Range (ATR) | 0.99 | 0.29 |
| MACD | 0.14 | -0.05 |
| Stochastic Oscillator | 90.86 | 3.42 |
Price Performance
Historical ComparisonAbout NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.